← Back to Search

Automatic vs. As-Needed Follow-Up for Infections (FAAN-C Trial)

N/A

Recruiting

Led By Eric Coon, MD

Research Sponsored by University of Utah

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Hospitalization due to a primary diagnosis of pneumonia, skin and soft tissue infection, acute gastroenteritis, or urinary tract infection

Age <18 years at the time of randomization

Must not have

Diagnosis of pneumonia complicated by: Receiving a chest tube

Presence of a comorbid disease that is both chronic and complex

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 7 days after hospital discharge

Awards & highlights

No Placebo-Only Group

Summary

This trial looks at whether automatic follow-up after being hospitalized for an infection is more effective than as-needed follow-up.

Who is the study for?

Children under 18 hospitalized for pneumonia, skin infections, gastroenteritis, or urinary tract infection can join. They must speak English or Spanish. Kids with chronic diseases, needing surgery beyond minor procedures, with immune issues, or scheduled follow-ups within a week of discharge cannot participate.

What is being tested?

The trial is testing if automatic follow-up appointments after hospitalization are better than scheduling them only as needed for children recovering from common infections like pneumonia and UTIs.

What are the potential side effects?

Since this trial involves follow-up methods rather than medication, there aren't direct side effects. However, the frequency of doctor visits could affect recovery comfort and convenience.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I was hospitalized for pneumonia, skin infection, stomach flu, or a UTI.

Select...

I am under 18 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have pneumonia and am receiving treatment with a chest tube.

Select...

I have a long-term, complex health condition.

Select...

My condition needed surgery beyond a simple cut and clean.

Select...

I have gastroenteritis with complications from hemolytic uremic syndrome.

Select...

I have a weakened immune system.

Select...

I don't have a clinic for follow-up after hospital.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 7 days after hospital discharge

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~7 days after hospital discharge

This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days after hospital discharge for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Hospital readmission

Secondary study objectives

Child health-related quality of life

Medical interventions

Other study objectives

Child time

Viral Load result

Communicable Diseases

+13 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: As-needed (PRN) post-hospitalization follow-upExperimental Treatment1 Intervention

At hospital discharge, participant receives a recommendation for PRN follow-up. Recommendation informs participant that scheduling a follow-up visit is not needed at discharge and suggests that participant follow symptoms after discharge to decide if a visit is ultimately needed or not.

Group II: Automatic post-hospitalization follow-upActive Control1 Intervention

At hospital discharge, participant receives a recommendation for automatic follow-up. Recommendation instructs participant to schedule a follow-up visit and attend the visit even if symptoms get better.

0 / 8Eligibility criteria met